Core Viewpoint - The company reported a mixed financial performance for 2024, with revenue growth but a significant decline in net profit, indicating challenges in maintaining profitability amidst competitive pressures in the market [1][2]. Financial Performance - In 2024, the company achieved a revenue of 797 million yuan, a year-on-year increase of 26.42%, while the net profit attributable to shareholders was 56 million yuan, down 30.51% year-on-year [1]. - The company's gross profit margin for 2024 was 25.52%, a decrease of 6.65 percentage points compared to the previous year [2]. - The net profit margin for 2024 was 6.90%, down 5.71 percentage points year-on-year, reflecting increased competition and reduced profit margins [2]. Cash Flow and Financial Health - The net cash flow from operating activities in 2024 was 31 million yuan, a decrease of 58.75% year-on-year, primarily due to rising product costs and increased procurement expenses [3]. - The net cash flow from investing activities was -284 million yuan, a decline of 433.73% year-on-year, attributed to the disposal of financial assets and investment returns [3]. - The net cash flow from financing activities increased to 133 million yuan, up 700.33% year-on-year, mainly due to increased bank borrowings [3]. Market Position and Product Offering - The company is a leading producer of mid-to-high-end flavoring agents in China, with a diverse product range including over 310 types of flavors, meeting various downstream application needs [4]. - The company has established stable relationships with major international flavor companies, ensuring a solid customer base and revenue growth [5]. - The global flavor and fragrance market is projected to grow, with the market size expected to reach approximately 32.1 billion USD by 2025, indicating a favorable environment for the company's growth [5][6]. Strategic Initiatives - The company is expanding its overseas market presence to mitigate geopolitical risks, with a new synthetic vanillin production line planned in Thailand [7]. - The Thai production facility has commenced full operations, contributing to performance growth, while domestic capacity expansion is underway [7]. - The company is adapting to new tariffs on imports, implementing a production adjustment plan to maintain competitiveness [7]. Future Outlook - The company is expected to achieve revenues of 1.406 billion yuan, 1.762 billion yuan, and 2.007 billion yuan for 2025-2027, with corresponding net profits of 223 million yuan, 294 million yuan, and 352 million yuan [8]. - The company is well-positioned to benefit from the expanding flavor and fragrance market and its new production capacities, leading to improved economic efficiency [8].

| 招商证券股份有限公司 | | | | | --- | --- | --- | --- | | 关于昆山亚香香料股份有限公司 | | | | | 保荐人名称：招商证券股份有限公司 | 被保荐公司简称：亚香股份 | | | | 联系电话：0755-83084021 保荐代表人姓名：覃建华 | | | | | 保荐代表人姓名：程建新 联系电话：0755-83084021 | | | | | 一、保荐工作概述 | | | | | 项目 工作内容 | | | | | （1）是否及时审阅公司信息披露文件 | | 是 | | | （2）未及时审阅公司信息披露文件的次数 | | | 无 | | （1）是否督导公司建立健全规章制度（包括但 | | | | | 不限于防止关联方占用公司资源的制度、募集资 | | | | | 是 | | | | | 金管理制度、内控制度、内部审计制度、关联交 | | | | | 易制度） | | | | | （2）公司是否有效执行相关规章制度 | | 是 | | | （1）查询公司募集资金专户次数 | | 8次 | | | （2）公司募集资金项目进展是否与信息披露文 | | | | | 是 | ...

Core Viewpoint - The company has experienced significant revenue growth in 2024, but net profit has declined due to intense price competition in the spice industry [2] Group 1: Financial Performance - In 2024, the company achieved a revenue of 797 million yuan, representing a year-on-year increase of 26.42%, while net profit attributable to shareholders was 56 million yuan, down 30.51% [2] - In Q1 2024, the company reported a record revenue of 262 million yuan and a net profit of approximately 82.17 million yuan, with a non-recurring net profit of 38.20 million yuan, marking a year-on-year growth of 120.8% [2] Group 2: Production Capacity and Expansion - The first phase of the "Yaxiang Biotechnology (Thailand) Co., Ltd. Production Base Project" commenced production in November 2024, with the Thai factory achieving normal full-load production [2] - The first phase capacity includes 1,000 tons of vanillin, 200 tons of oak moss, and other products, with a second phase expected to be completed around August 2025 [3] - A new synthetic vanillin production line is planned in Thailand, which will have an annual capacity of 4,000 tons [3] Group 3: Strategic Investments - The company plans to acquire 10% equity in Centrome Inc. for 30 million USD to expand sales channels and market share in the U.S. [3] - This investment is expected to enhance the company's international influence and complement its U.S. subsidiary's operations [3] Group 4: Market Strategy - The establishment of the Thai base allows the company to diversify its product structure and increase production capacity while avoiding tariff impacts [4] - The company is actively exploring new product layouts to meet diverse market demands, including the introduction of ambroxan, a fragrance ingredient commonly used in perfumes [4]

Group 1: Financial Performance - The company's net profit for 2024 is expected to decline due to four main factors: increased fixed asset depreciation, a 37% year-on-year increase in sales team size leading to higher sales expenses, increased R&D investment, and a structural decline in gross margin of core products due to intensified market competition [2][3] - In Q1 2025, the company reported a net profit growth of approximately 360%, attributed to investment income of about 40 million yuan and the efficient operation of the Thai production base [3] Group 2: Operational Insights - The Thai factory achieved approximately 90 million yuan in revenue and 19 million yuan in net profit in Q1 2025, primarily producing vanillin and cooling agents [3] - Long-term contracts account for about 80% of the company's total revenue, with pricing strategies adjusted based on market supply and demand dynamics [3][4] Group 3: Expansion and Product Development - The first phase of the Thai base is fully operational, with the second phase expected to be completed around August 2025, and the third phase in preliminary planning [3] - The company is actively exploring new product developments, such as ambroxan, to meet diverse market and consumer demands [4] - Strategic investment in ABT shares aims to strengthen sales channels and enhance market competitiveness [4]

3.公司未来在研发方面有何规划？是否会加大对新产品或新技 术的研发投入？ 证券代码：300886 证券简称：华业香料 答：尊敬的投资者，您好！未来，公司将继续秉持以市场为导向 的原则，聚焦技术迭代、新品开发、质量提升三大核心任务，坚定不 移地推进技术攻关工作。包括持续优化研发管理体系，提升创新效 能；前瞻性推动产品技术迭代，稳固主导产品的技术优势；强化新产 品技术开发力度，培育丰富的"产品树"；提升产品质量水平，进一 步增强产品竞争力；积极布局新兴赛道技术研发，大力推进生物发酵 产品技术研发等。感谢您的关注！ 安徽华业香料股份有限公司 4.高管您好。请问贵公司本期财务报告中，盈利表现如何？谢谢。 答：尊敬的投资者，您好！2024年，公司实现营业收入34,518.05 万元，同比增长28.12%；实现归属于上市公司股东的净利润2,208.99 万元，同比增长659.83%。2025年一季度，公司实现营业收入9,779.32 万元，同比增长24.06%；实现归属于上市公司股东的净利润1,145.28 万元，同比增长94.50%。感谢您的关注！ 投资者关系活动记录表 5.研发费用大幅增加，会为公司带来哪些具体的技术 ...

证券代码：920016 证券简称：中草香料 公告编号：2025-049 安徽中草香料股份有限公司 关于投资者关系活动记录表的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 一、 投资者关系活动类别 √特定对象调研 √业绩说明会 □媒体采访 活动地点：（一）全景网"投资者互动平台"（https://ir.p5w.net）以网络方式 召开业绩说明会。（二）线上会议。 参会单位及人员：（一）业绩说明会：通过网络方式参加 2024 年年度报告暨 2025 年第一季度报告业绩说明会的投资者。（二）线上会议：中泰研究、犁得尔 基金、非马投资、太平基金、观富资产、源乘基金、蜂巢基金、凯丰投资、紫阁 投资（以上排名不分先后）。 上市公司接待人员：（一）业绩说明会：公司董事长、总经理：李莉女士； 财务总监：赵慧女士；董事、董事会秘书：赵娅女士；保荐代表人：邵鸿波先生、 □现场参观 □新闻发布会 □分析师会议 □路演活动 □其他 二、 投资者关系活动情况 活动时间：2025 年 4 月 30 日 王三标先生。（二）线 ...

百润股份（ [Table_StockNameRptType] 002568） 公司点评 库存积极去化，威士忌招商可期 ——百润股份 24 年报&25Q1 点评 [Table_Rank] 投资评级：买入（维持） 报告日期： 2025-05-04 | [Table_BaseData] 收盘价（元） | 26.10 | | --- | --- | | 近 12 个月最高/最低（元） | 31.70/15.00 | | 总股本（百万股） | 1,049 | | 流通股本（百万股） | 718 | | 流通股比例（%） | 68.42 | | 总市值（亿元） | 274 | | 流通市值（亿元） | 187 | [公司价格与沪深 Table_Chart] 300 走势比较 -39% -17% 5% 26% 48% 5/24 8/24 11/24 2/25 百润股份 沪深300 [Table_Author] 分析师：邓欣 执业证书号：S0010524010001 邮箱：dengxin@hazq.com 联系人：郑少轩 执业证书号：S0010124040001 [Table_CompanyReport] 相关报告 1.百润 ...

-39% -17% 5% 26% 48% 5/24 8/24 11/24 2/25 百润股份 沪深300 [Table_Rank] 投资评级：买入（维持） 报告日期： 2025-05-04 | [Table_BaseData] 收盘价（元） | 26.10 | | --- | --- | | 近 12 个月最高/最低（元） | 31.70/15.00 | | 总股本（百万股） | 1,049 | | 流通股本（百万股） | 718 | | 流通股比例（%） | 68.42 | | 总市值（亿元） | 274 | | 流通市值（亿元） | 187 | [公司价格与沪深 Table_Chart] 300 走势比较 [Table_Author] 分析师：邓欣 执业证书号：S0010524010001 邮箱：dengxin@hazq.com 联系人：郑少轩 执业证书号：S0010124040001 百润股份（ [Table_StockNameRptType] 002568） 公司点评 库存积极去化，威士忌招商可期 ——百润股份 24 年报&25Q1 点评 [Table_CompanyReport] 相关报告 1.百润 ...

Financial Overview - The company achieved significant growth in Q1 2025, with total revenue reaching 262 million yuan, a year-on-year increase of 50.28% [1] - The net profit attributable to shareholders was 82.17 million yuan, a substantial year-on-year increase of 361.70% [1] - The net profit after deducting non-recurring items was 38.20 million yuan, reflecting a year-on-year growth of 120.80% [1] Profitability Analysis - The company's gross margin was 31.58%, an increase of 18.52 percentage points year-on-year [2] - The net profit margin reached 31.35%, showing a significant year-on-year increase of 210.16 percentage points [2] - This indicates notable improvements in product value addition and service quality [2] Cost and Expenses - Despite revenue and profit growth, the proportion of the company's three expenses (selling, administrative, and financial expenses) to revenue increased from 9.46% in the same period last year to 12.68%, a rise of 34.05% [3] - This suggests potential pressure on cost control during operations [3] Asset and Liability Situation - As of the end of the reporting period, the company's cash and cash equivalents amounted to 256 million yuan, a decrease of 31.57% year-on-year [4] - Accounts receivable increased to 292 million yuan, a year-on-year growth of 44.09%, with accounts receivable to profit ratio reaching 524.82%, necessitating close monitoring of collection [4] - Interest-bearing liabilities also increased to 345 million yuan, a year-on-year rise of 73.42% [4] Per Share Indicators - The net asset per share was 21.20 yuan, a year-on-year increase of 9.17% [5] - Earnings per share were 1.02 yuan, reflecting a year-on-year growth of 363.64% [5] - Operating cash flow per share was 0.49 yuan, a significant year-on-year increase of 405.36% [5] Business Model and Financing Dividends - The company's performance primarily relies on R&D, equity financing, and capital expenditures [6] - Since its listing, the total financing amount has reached 727 million yuan, with total dividends distributed amounting to 40.40 million yuan, resulting in a dividend financing ratio of only 0.06 [6] - Overall, while the company showed excellent performance in Q1 2025, the rising expense ratio and rapid growth in accounts receivable warrant further attention from investors [6]

2025 年 4 月 30 日 公司研究 预调鸡尾酒需求仍较疲软，威士忌业务有望提供新增长动能 ——百润股份（002568.SZ）2024 年年报及 2025 年一季报点评 增持（维持） 当前价：26.33 元 作者 分析师：陈彦彤 执业证书编号：S0930518070002 021-52523689 chenyt@ebscn.com 分析师：汪航宇 执业证书编号：S0930523070002 021-52523174 wanghangyu@ebscn.com 分析师：聂博雅 执业证书编号：S0930522030003 021-52523808 nieboya@ebscn.com | 市场数据 | | | --- | --- | | 总股本(亿股) | 10.49 | | 总市值(亿元)： | 276.30 | | 一年最低/最高(元)： | 15.00/31.70 | | 近 3 月换手率： | 55.04% | 股价相对走势 -25% -7% 11% 29% 47% 04/24 07/24 10/24 01/25 百润股份 沪深300 | 收益表现 | | | | | --- | --- | --- | ...